Does Anthem Cover Metformin?

How Anthem Classifies Metformin on Its Formulary

Anthem places generic metformin hydrochloride immediate-release (IR) on Tier 1 across its commercial PPO, HMO, and EPO drug lists. Tier 1 carries the lowest member cost-share, ranging from $0 on many high-deductible health plans (HDHPs) with pre-deductible pharmacy benefits to $15 on traditional copay plans.

The classification reflects metformin's status as the most-prescribed oral antidiabetic drug in the United States. The American Diabetes Association (ADA) 2024 Standards of Care names metformin a first-line pharmacologic agent for type 2 diabetes in adults with an eGFR of 30 mL/min/1.73 m² or above 1. That guideline endorsement is one reason every major insurer, Anthem included, keeps metformin at the lowest tier. The drug's wholesale acquisition cost sits below $0.10 per 500 mg tablet, making it one of the cheapest branded molecules in any pharmacy formulary 2.

Extended-release metformin (metformin ER) occupies Tier 1 or Tier 2 depending on the specific Anthem plan. Some Anthem Medicare Advantage plans moved certain ER generics to Tier 2 after the 2020 recall of specific manufacturers' ER tablets due to NDMA contamination concerns, though reinstated products have largely returned to Tier 1 2. If your plan lists metformin ER at Tier 2, expect a copay between $10 and $25 for a 30-day supply.

Brand-name Glucophage and Glucophage XR are either placed on Tier 3 (preferred brand, with copays of $35, $60) or excluded from the formulary entirely. There is no clinical advantage to the brand over the generic, so Anthem rarely grants exceptions for brand-name requests unless a patient documents intolerance to all available generic manufacturers.

What You Will Pay Out of Pocket With Anthem

The actual dollar amount depends on your plan design. Here is a realistic range.

For Anthem commercial plans (employer-sponsored or ACA Marketplace), generic metformin IR costs between $0 and $10 per month on most copay-based designs. Plans with coinsurance instead of flat copays typically charge 10%, 20% of the negotiated drug cost, which on a drug this inexpensive still comes to under $5. Anthem HDHPs that classify metformin as a preventive drug under IRS safe-harbor rules may waive the deductible entirely, allowing $0 cost-share 3.

Anthem Medicare Advantage Part D plans follow CMS formulary guidelines. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D drugs (effective 2025), metformin costs are further compressed. Many Anthem Medicare Enhanced plans already offered $0 Tier 1 generics before the cap took effect.

Anthem Medicaid managed-care plans in states like California (Medi-Cal), Georgia, Indiana, and Ohio typically assign $0, $3 copays on preferred generics. Metformin qualifies. Some state programs prohibit any copay on antidiabetic medications.

Without insurance, cash-pay metformin IR 500 mg #60 averages $4 to $9 at major chain pharmacies through discount programs. The drug is on Walmart's $4 list and is covered by Mark Cuban's Cost Plus Drugs at $3.60 for a 30-day supply. Even patients with Anthem coverage sometimes find it cheaper to use a discount card than process the claim, particularly on high-deductible plans where the deductible has not been met.

Prior Authorization and Step Therapy Rules

Metformin does not require prior authorization on any standard Anthem formulary for its FDA-approved indication of type 2 diabetes mellitus. This is true across commercial, Medicare, and Medicaid lines of business.

In fact, metformin often sits on the other side of the step-therapy equation. Anthem requires patients to try and fail metformin before covering more expensive agents like SGLT2 inhibitors or GLP-1 receptor agonists for glycemic control. The AACE 2023 Consensus Statement recommends metformin as a foundational therapy that should be continued even when newer agents are added 4. A prescriber who wants to start a patient on semaglutide (Ozempic) or tirzepatide (Mounjaro) for type 2 diabetes will usually need to document a metformin trial or contraindication first.

The only scenario where Anthem may request documentation is off-label prescribing at unusually high quantities. Metformin prescribed for polycystic ovary syndrome (PCOS) at doses above 2 to 000 mg/day, or metformin prescribed explicitly for "longevity" or "anti-aging," could trigger a quantity limit edit at the pharmacy. The fix is straightforward: the prescriber submits a brief clinical rationale citing the relevant diagnosis code (E28.2 for PCOS, or E11.9 for prediabetes/metabolic syndrome), and the claim processes.

Off-Label Coverage: PCOS, Prediabetes, and Longevity

Anthem covers metformin for several off-label indications when prescribed by a licensed provider, even though the FDA label specifies type 2 diabetes only.

Prediabetes and diabetes prevention. The Diabetes Prevention Program (DPP) trial (N=3,234) demonstrated that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% over 2.9 years compared to placebo 5. The 15-year follow-up confirmed sustained benefit 6. The ADA recommends metformin for prediabetes prevention in adults with BMI ≥35, those under age 60, or women with prior gestational diabetes 1. Anthem covers this use without prior authorization when the claim is coded under prediabetes (R73.03) or glucose intolerance (R73.09).

Polycystic ovary syndrome. The Endocrine Society Clinical Practice Guideline recommends metformin as a second-line agent for menstrual irregularity in PCOS when hormonal contraceptives are contraindicated or not tolerated 7. Anthem formulary edits generally allow 1,500, 2 to 000 mg/day for this indication.

Longevity and healthspan. This is newer territory. The TAME (Targeting Aging with Metformin) trial, a planned multicenter RCT of 3,000 adults aged 65, 79, aims to test whether metformin 1 to 500 mg/day delays a composite of age-related diseases including cardiovascular events, cancer, dementia, and mortality 8. The trial has received IND clearance from the FDA. Observational data from the UK Prospective Diabetes Study (UKPDS) showed that metformin-treated patients with type 2 diabetes had lower all-cause mortality than matched non-diabetic controls, a finding that generated significant interest in metformin's potential geroprotective effects 9.

Anthem does not have an explicit "longevity" exclusion in its formulary. If a prescriber writes metformin for a recognized diagnosis code (prediabetes, insulin resistance, metabolic syndrome), the claim will process at the standard Tier 1 copay regardless of the prescriber's clinical reasoning about aging biology. The practical barrier is not insurance coverage. It is finding a clinician willing to prescribe for this indication.

Metformin Extended-Release vs. Immediate-Release: Coverage Differences

Most patients tolerate metformin IR well, but gastrointestinal side effects (diarrhea, nausea, abdominal cramping) affect 20%, 30% of users in the first weeks 10. Extended-release formulations reduce GI complaints substantially. A 2004 randomized crossover trial found that metformin ER produced 50% fewer GI adverse events than IR at equivalent doses 11.

Anthem covers the following ER formulations:

Generic metformin ER 500 mg and 750 mg tablets from approved manufacturers sit on Tier 1 or Tier 2. Riomet ER (liquid metformin extended-release) lands on Tier 3 or requires prior authorization due to its significantly higher cost ($400+ per month vs. under $20 for generic ER tablets). Glumetza, a once-daily brand ER tablet, is excluded from most Anthem formularies.

If your pharmacy fills a generic ER metformin and the claim rejects, the most common reason is a manufacturer-specific National Drug Code (NDC) block left over from the 2020 NDMA recalls. Ask the pharmacist to try a different manufacturer's NDC. Alternatively, the prescriber can submit a formulary exception request, which Anthem typically processes within 72 hours for non-urgent requests and 24 hours for urgent/expedited requests.

How to Verify Your Specific Anthem Plan's Coverage

Anthem operates across 14 states under the Blue Cross Blue Shield license, and formularies vary by state, plan type, and employer group. Do not assume that a neighbor's Anthem plan matches yours.

The fastest verification method is Anthem's online formulary lookup tool. Log in to anthem.com, manage to "Find a Drug," and enter "metformin." The tool will display tier placement, quantity limits, and any prior authorization requirements specific to your plan ID. You can also call the member services number on your insurance card and ask the representative to run a "test claim" or "benefit inquiry" for metformin at your preferred pharmacy.

For Anthem Medicare Advantage members, CMS maintains an independent formulary finder at medicare.gov/plan-compare that cross-references Anthem's submitted formulary data. This tool is especially useful for comparing Anthem's metformin coverage against competing Medicare Advantage plans during Annual Enrollment (October 15 through December 7).

Pharmacy benefit managers (PBMs) complicate the picture. Anthem uses IngenioRx as its integrated PBM for most commercial plans, but some large employer groups carve out pharmacy benefits to Express Scripts or CVS Caremark. If your pharmacy claim rejects, confirm which PBM administers your drug benefit before calling Anthem medical.

What to Do If Anthem Denies a Metformin Claim

Outright denials for generic metformin IR are rare. They happen. The most common denial reasons are: incorrect diagnosis code on the prescription, quantity exceeding plan limits, a pharmacy billing error, or the member's deductible has not been met on a plan without pre-deductible drug coverage.

Step one is calling the pharmacy. Many "denials" are actually real-time claim edits that the pharmacist can resolve by correcting the days' supply, quantity, or DAW (dispense as written) code. This takes five minutes.

If the denial persists, request a formulary exception from Anthem. The prescriber must submit a letter explaining medical necessity. For on-label type 2 diabetes, this is a formality. For off-label uses, cite the ADA Standards of Care 1 or the relevant Endocrine Society guideline 7.

Anthem must respond to standard exception requests within 72 hours and expedited requests within 24 hours under CMS and state insurance regulations. If the exception is denied, you have the right to an external independent review. For Medicare Advantage denials, the appeals process goes through Anthem's internal review, then to an Independent Review Entity (IRE), and ultimately to an Administrative Law Judge if the amount in controversy exceeds $180 (2025 threshold).

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the ADA, has stated: "Metformin remains the most cost-effective first-line therapy for type 2 diabetes, and insurance barriers to this medication are both clinically inappropriate and economically counterproductive" 1.

Metformin Costs: Anthem vs. Cash Pay vs. Discount Programs

A direct comparison clarifies when insurance adds value and when it does not.

With Anthem Tier 1 coverage, metformin IR 500 mg #60 costs $0, $10 per month after any applicable copay. With a GoodRx or RxSaver discount card (no insurance), the same prescription runs $4, $9 at most chain pharmacies. Through Cost Plus Drugs (Mark Cuban's pharmacy), metformin 500 mg #60 is priced at $3.60 plus a $5 shipping fee for mail-order.

The math changes at higher doses. Metformin 1 to 000 mg twice daily (requiring #60 of the 1 to 000 mg tablets or #120 of the 500 mg tablets) costs $8, $18 cash vs. $0, $15 through Anthem. For extended-release at 2 to 000 mg/day, generic ER tablets run $12, $30 cash vs. $0, $25 through Anthem.

The inflection point where Anthem coverage clearly saves money is brand-name or specialty formulations. Riomet ER oral solution lists at approximately $475/month. With Anthem Tier 3 coverage, the copay drops to $35, $60. Without insurance, that price is prohibitive for most patients.

For patients on high-deductible Anthem plans who have not met their deductible, the discount card route may be cheaper for generic metformin. There is no rule against using a discount card instead of your insurance. The prescription simply does not count toward your deductible or out-of-pocket maximum.

Metformin Safety Monitoring Anthem May Require

Anthem does not mandate specific lab monitoring as a condition of metformin coverage, but your prescriber should follow evidence-based monitoring guidelines regardless of insurance requirements.

The FDA label recommends checking eGFR before initiation and at least annually thereafter 2. The 2016 FDA label revision expanded metformin's use to patients with eGFR 30 to 45 mL/min/1.73 m² (previously contraindicated below 60), though dose reduction to a maximum of 1 to 000 mg/day is recommended in that range.

Vitamin B12 deficiency is an underrecognized consequence of long-term metformin use. A secondary analysis of the DPP Outcomes Study found that metformin users had a 13% absolute risk of B12 deficiency (<203 pg/mL) at year 5 compared to 2% in the placebo group 12. The ADA recommends periodic B12 measurement in patients on metformin, particularly those with peripheral neuropathy or macrocytic anemia 1. Anthem covers serum B12 testing as a standard lab benefit.

Lactic acidosis, once considered metformin's most feared complication, occurs at an estimated rate of 3, 10 per 100,000 patient-years, and a Cochrane systematic review of 347 trials found no increased risk compared to other antidiabetic therapies 13. The risk is clinically relevant only in acute kidney injury, sepsis, or other states of tissue hypoxia. Hold metformin 48 hours before and after iodinated contrast procedures if eGFR is <60.